Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flurbiprofen gel patch vs loxoprofen sodium cataplasm for knee osteoarthritis
ChiCTR2100054822Phase 4Recruiting
- Sponsor
- Peking University Shougang Hospital
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in knee osteoarthritis (OA) comparing Flurbiprofen gel patch with Loxoprofen sodium cataplasm (2 arms). Primary endpoint: Pain VAS score. Started Nov 2021; status: recruiting.
02
Drugs
flurbiprofenloxoprofen
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on ChiCTR2100054822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100054822.